Mirae Asset Global ETFs Holdings
CRGX

Mirae Asset Global ETFs Holdings’s CARGO Therapeutics CRGX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CRGX Stock Details CRGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,929
Closed -$222K – 3104
2025
Q2 		$222K Buy
53,929
+33,367
+162% +$143K ﹤0.01% 2227
2025
Q1 		$83.7K Sell
20,562
-440
-2% -$2.95K ﹤0.01% 2710
2024
Q4 		$302K Buy
21,002
+1,127
+6% +$20.5K ﹤0.01% 2167
2024
Q3 		$366K Buy
19,875
+6,963
+54% +$125K ﹤0.01% 2074
2024
Q2 		$211K Buy
+12,912
New +$245K ﹤0.01% 2223

Other funds holding CRGX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CRGX Position: Q3 2025 in Review

Mirae Asset Global ETFs Holdings sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 53,929 shares — an estimated $222K sold.

Mirae Asset Global ETFs Holdings first reported a position in CRGX in Q2 2024 and held it in 5 quarters. The position peaked at $366K in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 53,929 CARGO Therapeutics shares in Q3 2025, an estimated $222K.
  • Mirae Asset Global ETFs Holdings first reported a position in CARGO Therapeutics in Q2 2024 and held it in 5 quarters.
  • Mirae Asset Global ETFs Holdings's CARGO Therapeutics position peaked at $366K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.